What’s more, the tight correction between IL-6 signaling pathways and epigenetic regulations has furthermore disclosed by a clinical investigation of colorectal cancer, displaying that in tumor tissues refraining HDAC activation or neutralizing IL-6 substantially inhibits the expression of genes related to immunosuppression and chemotaxis of MDSCs [158]. Here, HDAC9 is linked to neoplasm.